Danone Baby Formula Recall Lawsuit | 2026 Latest Updates

What’s the Problem?

Public reporting indicates Danone was among several infant formula manufacturers affected by a broader cereulide contamination crisis involving ingredients supplied to the sector. Reuters reported that Danone said the recall disruption could create a one-time first-quarter 2026 sales impact, while the company maintained confidence in its broader annual outlook.

Danone also published a press release stating that, in response to evolving local food safety guidance, it would withdraw a very limited number of specific infant formula batches from targeted markets. Danone said the action was taken to comply with the latest guidance and emphasized that parents could contact Danone’s careline with questions.

Latest Updates

• February 20, 2026 – Reuters reported Danone said the widespread baby formula recall was likely to have a one-off impact of 0.5% to 1% on first-quarter group sales, while the company said the impact was not material and a final assessment would follow completion of the recalls. [1]
• February 19, 2026 – Reuters reported EU food and disease authorities assessed infant exposure risk as low after large-scale control measures, while noting reported gastrointestinal cases in several European countries and some hospitalizations for dehydration. [3]
• February 18, 2026 – Reuters reported Swiss authorities said traces of cereulide were found in two recalled Danone infant formula products and that 20 reports of possible illness had been received since February 3. [4]
• February 5-6, 2026 – Reuters reported Danone widened recalls across Europe after EFSA guidance on a cereulide threshold, including around 130 batches of Aptamil and Milumil sold in Austria and Germany, with additional precautionary withdrawals in France. [5]

Recalled Products and Product Scope

This is a multi-product, multi-market situation, not a single U.S. FDA recall notice with one SKU list. Public reports describe recalls involving Danone infant formula products sold under brands including Aptamil and Milumil in some European markets, with other Danone baby nutrition brands referenced in France.

Because multiple notices and country-level actions were involved, families should not rely on a generic article title alone to identify affected products. Product name, batch code, package size, and country-specific recall instructions remain critical for confirming whether a specific formula is included.

• Aptamil formula products (multiple batches reported in some markets)
• Milumil formula products (multiple batches reported in some markets)
• Certain Gallia brand batches (reported precautionary withdrawals in France)
• Certain Bledina brand batches (reported precautionary withdrawals in France)

Examples Reported by Reuters and Swiss Authorities

Reuters reported Swiss authorities identified cereulide traces in two recalled Danone products: Aptamil Pronutra 1, 1.2 kg, and Aptamil Pronutra Junior 12+. Reuters also reported Danone recalled both products on February 5, according to the Swiss Federal Food Safety and Veterinary Office statement.

These examples do not necessarily define the full global recall scope. Country-by-country notices may differ based on local guidance, testing, and enforcement decisions.

Cereulide and Potential Symptoms

Reuters consistently described cereulide as a toxin that can cause nausea and vomiting. Reporting also noted concern that infants with gastrointestinal symptoms may require monitoring and, in some cases, hospitalization for dehydration.

Parents and caregivers should seek prompt medical care if an infant develops vomiting, poor intake, or signs of dehydration after consuming a potentially affected formula. Early records can be important for both treatment and any later legal review.

Illness Reports and Ongoing Investigations

Reuters reported that, as of February 13, seven European countries had reported infants with gastrointestinal symptoms after consuming affected formula, and that most cases were mild, though some infants were hospitalized for dehydration. Reuters also reported French investigators were examining deaths of three babies who consumed formula covered by precautionary recalls, while noting no scientific causal link had been established.

Separately, Reuters reported Swiss authorities had received 20 reports of possible illness since February 3 in connection with the broader situation. Illness reports alone do not prove causation in any individual case.

Do You Qualify for a Danone Baby Formula Recall Lawsuit?

You may have a potential claim if your infant consumed a Danone product later identified in a recall or withdrawal and then developed symptoms requiring medical care. A stronger claim usually depends on proving product identity, exposure timing, and injury documentation.

Public reporting has focused on recall scope and business impact, but many legal claims rise or fall on specific batch-level evidence. Packaging, receipts, and medical records are usually more important than general news headlines.

Evidence to Gather

• Formula cans or packaging with product name, batch code, and expiration date
• Retail receipts, pharmacy records, or online purchase confirmations
• Medical records, emergency visits, hospital records, and pediatric notes
• A timeline of feeding dates, symptoms, and treatment
• Any recall notices, retailer messages, or manufacturer communications

Potential Damages

Potential damages may include medical expenses, emergency care, hospitalization costs, follow-up treatment, and related out-of-pocket losses. Depending on the facts and applicable law, families may also seek compensation for lost income and other documented impacts.

Legal Theories and Liability Considerations

Infant formula contamination cases are often evaluated under product liability, negligence, failure-to-warn, and breach of warranty theories. Case analysis usually centers on contamination evidence, recall scope, causation, and whether warnings and withdrawals were timely and adequate.

A recall or withdrawal report does not automatically establish liability against any company in an individual case. It can, however, be an important factual component in a broader investigation of potential claims.

Frequently Asked Questions

• Is there a confirmed U.S. class action already filed for this exact Danone recall event?
  Public reporting cited here focuses on recalls, investigations, and business impact, not a finalized class action outcome.
• Should I stop using all Danone formula products?
  Product decisions should be based on official recall notices and batch-specific instructions in your country, not assumptions from general reporting.
• What if I no longer have the can?
  You may still have options, but missing packaging can make product identification and claim review more difficult.

Why You Should Act Now

Infant formula cases often depend on records that disappear quickly, including packaging, batch codes, and retailer data. Early documentation can significantly improve a legal review and help preserve your options.

References

1. https://www.reuters.com/world/china/food-group-danone-confident-over-2026-after-china-drives-2025-sales-beat-2026-02-20/
2. https://www.danone.com/newsroom/press-releases/recall-specific-infant-formula-batches.html
3. https://www.reuters.com/business/healthcare-pharmaceuticals/eu-says-cereulide-exposure-risk-low-after-baby-formula-recalls-2026-02-19/
4. https://www.reuters.com/business/healthcare-pharmaceuticals/cereulide-found-two-baby-formula-products-recalled-by-danone-switzerland-says-2026-02-18/
5. https://www.reuters.com/business/healthcare-pharmaceuticals/danone-recalls-120-batches-infant-formula-austria-germany-bloomberg-news-reports-2026-02-05/